Utility of a Fluorescence Microscopy Imaging System for Analyzing the DNA Ploidy of Pathological Megakaryocytes Including 5q-Syndrome

被引:0
作者
Nakahara, Takako [1 ,2 ,3 ,4 ]
Suemori, Shin-ichiro [3 ]
Tsujioka, Takayuki [3 ]
Kataoka, Mikio [2 ]
Kataoka, Hiromi [4 ]
Shibakura, Misako [2 ]
Tohyama, Kaoru [1 ,3 ,4 ]
机构
[1] Kawasaki Coll Allied Hlth Profess, Div Med Technol, Kurashiki, Okayama 7010194, Japan
[2] Okayama Univ, Grad Sch Hlth Sci, Dept Med Technol, Okayama 7008558, Japan
[3] Kawasaki Med Sch, Dept Lab Med, Kurashiki, Okayama 7010192, Japan
[4] Kawasaki Univ Med Welf, Dept Med Technol, Kurashiki, Okayama 7010193, Japan
关键词
fluorescence microscopy image analysis; DNA ploidy; megakaryocytes; MDS with isolated del(5q); 5q-syndrome; FLOW-CYTOMETRY PROJECT; MYELODYSPLASTIC SYNDROME; POLYPLOIDY; CELLS; DIFFERENTIATION;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
To investigate megakaryocyte (MK) DNA ploidy in various hematological diseases, fluorescence microscopy imaging system (FMI) can be used to analyze DNA ploidy with cell morphology at the single-cell level by using specialized image-processing software. Here we compared DNA ploidy obtained by FMI measured with that obtained flow cytometry (FCM). With FMI, we could evaluate the DNA ploidy in long-term preserved bone marrow smear samples after staining. We next analyzed the MK DNA ploidy in 42 bone marrow smear samples including 26 myeloid neoplasm cases, and we compared the DNA ploidy and platelet counts in the patients' peripheral blood; the production of platelets was significantly high compared to DNA ploidy in the myeloproliferative neoplasms group. The FMI method revealed that the patients with 5q- syndrome exhibited relatively low DNA ploidy despite high platelet counts, and this result suggested that increased DNA ploidy is not indispensable to abundant platelet production. The FMI method for DNA ploidy will be a useful tool to clarify the relationship between DNA ploidy and platelet production by MKs.
引用
收藏
页码:249 / 256
页数:8
相关论文
共 30 条
[1]   Equivalence of laser scanning cytometric and flow cytometric immunophenotyping of lymphoid lesions in cytologic samples [J].
Al-Za'abi, Ali Mohammed ;
Geddie, William B. ;
Boerner, Scott L. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 129 (05) :780-785
[2]   In Vitro Megakaryocyte Differentiation and Proplatelet Formation in Ph-Negative Classical Myeloproliferative Neoplasms: Distinct Patterns in the Different Clinical Phenotypes [J].
Balduini, Alessandra ;
Badalucco, Stefania ;
Pugliano, Maria Teresa ;
Baev, Denis ;
De Silvestri, Annalisa ;
Cattaneo, Marco ;
Rosti, Vittorio ;
Barosi, Giovanni .
PLOS ONE, 2011, 6 (06)
[3]  
Darzynkiewicz Z, 2010, ADV EXP MED BIOL, V676, P137
[4]   Megakaryocyte polyploidy is inhibited by lysyl oxidase propeptide [J].
Eliades, Alexia ;
Papadantonakis, Nikolaos ;
Matsuura, Shinobu ;
Mi, Rongjuan ;
Bais, Manish V. ;
Trackman, Philip ;
Ravid, Katya .
CELL CYCLE, 2013, 12 (08) :1242-1250
[5]   In vitro response of myelodysplastic megakaryocytopoiesis to megakaryocyte growth and development factor (MGDF) [J].
Faulhaber, M ;
Wörmann, B ;
Ganser, A ;
Verbeek, W .
ANNALS OF HEMATOLOGY, 2002, 81 (12) :695-700
[6]  
Gallardo-Escárate C, 2007, BIOL RES, V40, P29, DOI 10.4067/S0716-97602007000100004
[7]   Aurora kinase A is required for hematopoiesis but is dispensable for murine megakaryocyte endomitosis and differentiation [J].
Goldenson, Benjamin ;
Kirsammer, Gina ;
Stankiewicz, Monika J. ;
Wen, Qiang Jeremy ;
Crispino, John D. .
BLOOD, 2015, 125 (13) :2141-2150
[8]   SHIFT IN THE MEGAKARYOCYTE PLOIDY IN MDS PATIENTS - MICROCYTOFLUOROMETRY WITH DAPI STAINING AFTER DESTAINING OF WRIGHT-GIEMSA STAIN [J].
KOBAYASHI, Y ;
KIMURA, S ;
TANAKA, K ;
WADA, K ;
OZAWA, M ;
HORIUCHI, H ;
MARUO, N ;
KONDO, M .
BRITISH JOURNAL OF HAEMATOLOGY, 1991, 79 (04) :556-561
[9]   MEGAKARYOCYTIC PLOIDY IN MYELODYSPLASTIC SYNDROMES [J].
KOBAYASHI, Y ;
OZAWA, M ;
MARUO, N ;
KONDO, M .
LEUKEMIA & LYMPHOMA, 1993, 9 (1-2) :55-61
[10]   Molecular Pathways: Induction of Polyploidy as a Novel Differentiation Therapy for Leukemia [J].
Krause, Diane S. ;
Crispino, John D. .
CLINICAL CANCER RESEARCH, 2013, 19 (22) :6084-6088